A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Iron/IBC
Test CodeCPT Codes
83540; 83550
Includes
Preferred Specimen
Serum (gold or red top tube)
Minimum Volume
Transport Container
Serum (gold or red top) Tube
Transport Temperature
Specimen Stability
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Photometric
Setup Schedule
Daily upon receipt
Report Available
Limitations
Reference Range
Iron (Female): 37 - 170 mg/dL
Iron (Male): 49 - 181 mg/dL
TIBC (Female): 265 - 497 ug/dL
TIBC (Male): 261 - 462 ug/dL
% Iron Sat: 11 - 40%
Clinical Significance
Ingested iron is absorbed primarily from the intestinal tract and is temporarily stored in the mucosal cells as Fe(III)-ferritin. Ferritin provides a soluble protein shell to encapsulate a complex of insoluble ferric hydroxide-ferric phosphate. On demand, iron is released into the blood by mechanisms that are not clearly understood, to be transported as Fe(III)-transferrin. Transferrin is the primary plasma iron transport protein, which binds iron strongly at physiological pH. Transferrin is generally only 25% to 30% saturated with iron. The additional amount of iron that can be bound is the unsaturated iron-binding capacity (UIBC). The total iron binding capacity (TIBC) can be indirectly determined using the sum of the serum iron and UIBC. Knowing the molecular weight of the transferrin and that each molecule of transferrin can bind 2 atoms of iron, TIBC and transferrin concentration is interconvertible. Percent saturation (100 x serum iron/TIBC) is usually normal or increased in persons who are iron deficient, pregnant, or are taking oral contraceptive medications. Persons with chronic inflammatory processes, hemochromatosis, or malignancies generally display low transferrin.